WSJ – Samlyn Capital LLC, a hedge fund founded by a veteran of SAC Capital Advisors LP, has built a $150 million stake in Allergan Inc. AGN +0.95% and is weighing whether to support Valeant Pharmaceuticals International Inc. VRX.T +0.06% ‘s hostile bid for the maker of Botox.
Samlyn’s stake was detailed in the hedge fund’s confidential investor documents obtained by The Wall Street Journal and confirmed by people familiar with the firm. Allergan’s current market capitalization is about $50 billion.
